T1	Participants 55 72	autistic disorder
T2	Participants 308 326	pediatric subjects
T3	Participants 550 608	pediatric subjects with autistic disorder, aged 6-17 years
T4	Participants 610 641	Subjects were stratified by PAE
T5	Participants 234 268	prior antipsychotic exposure (PAE)
T6	Participants 913 1004	316 randomized subjects, 259 (82.0%) were antipsychotic na√Øve (AN) and 57 (18.0%) had a PAE
T7	Participants 1819 1863	younger subjects with higher baseline weight
T8	Participants 2092 2146	younger subjects with a higher baseline weight z-score
T9	Participants 2397 2444	children and adolescents with autistic disorder
